Predictors of Initial and Sustained Remission in Patients Treated with Antithyroid Drugs for Graves’ Hyperthyroidism: The RISG Study

Figure 2

Event curve of patients achieving remission depending on whether initial TRAb was below (black) or above (grey) 10 IU/L. Remission was TRAb < 1.0 IU/L and TSH ≥ 0.40 mU/L on a MMI dose of 5 mg or less per day evaluated twice, two months apart.